Takeda Pharmaceutical TAK
NYSE TAK
$17.87 -0.32 (-1.76%)
As of: Oct 1, 2026 · 3:59 PM EDT

Takeda Pharmaceutical (TAK) Net Income (2017 - 2026)

Updated

Takeda Pharmaceutical (TAK) reported Net Income of $710.56 million for the quarter ended Jun 30, 2026, down 17.3% from $858.91 million a year earlier and down 10.4% from the prior quarter.

Analysis

Takeda Pharmaceutical (TAK) Net Income (2017 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Takeda Pharmaceutical's Net Income came in at $577.31 million, down 76.1% year-over-year; for the year ended Mar 31, 2026, it came in at -$1.01 billion.

  • By year, Net Income came in at $709.94 million in the year ended Mar 31, 2025 (-29.0%), $999.88 million in the year ended Mar 31, 2024 (-57.4%), $2.35 billion in the year ended Mar 31, 2023 (+14.5%) and $2.05 billion in the year ended Mar 31, 2022 (-42.2%).
  • Five-year quarterly Net Income spans a low of -$2.39 billion in the quarter ended Dec 31, 2025 and a high of $1.98 billion in the quarter ended Sep 30, 2023.
  • Year over year, Net Income gained in three of the last six quarters, with growth averaging 3.7%.
  • The high point for year-over-year Net Income in five years was the quarter ended Sep 30, 2023 (growth of 342.9%); the low point was the quarter ended Dec 31, 2023 (a decline of 75.1%).
  • Per Business Quant data, the three quarters before the quarter ended Jun 30, 2026 came in at $792.61 million (quarter ended Mar 31, 2026), -$2.39 billion (quarter ended Dec 31, 2025) and $1.47 billion (quarter ended Sep 30, 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 5.53 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 3.62 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -1.34 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 3.26 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 2.51 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 2.38 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -10.50 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -237.00 Mn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 1.10 Bn
10 Takeda Pharmaceutical 2.63 Bn -23.88 Bn 5.10 Bn 710.56 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 710.56 Mn
Mar 31, 2026 792.61 Mn
Dec 31, 2025 -2.39 Bn
Sep 30, 2025 1.47 Bn
Jun 30, 2025 858.91 Mn
Mar 31, 2025 814.74 Mn
Dec 31, 2024 -678.17 Mn
Sep 30, 2024 1.42 Bn
Jun 30, 2024 612.19 Mn
Mar 31, 2024 643.07 Mn
Dec 31, 2023 210.40 Mn
Sep 30, 2023 1.98 Bn
Jun 30, 2023 652.39 Mn
Mar 31, 2023 793.80 Mn
Dec 31, 2022 843.37 Mn
Sep 30, 2022 446.97 Mn
Jun 30, 2022 812.06 Mn
Mar 31, 2022 1.18 Bn
Jun 30, 2021 1.26 Bn
Mar 31, 2021 1.89 Bn
API Access

Takeda Pharmaceutical Net Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-income&ticker=TAK&period=max&api_key=YOUR_API_KEY